Want to listen to the blog? Thanks to Geoff for providing a narration of it. 🙂 The multiple sclerosis drug Copaxone (glatiramer acetate) is back in the chronic fatigue syndrome (ME/CFS) news. Health Rising first reported that Copaxone helped some ME/CFS...
Will we ever get away from the vaccine question? Probably not but at least we’re getting studies on their effects not just on COVID-19 but on getting long COVID and even healing from it. While they’re not on chronic fatigue syndrome (ME/CFS) they’re...
One of the dangers facing the long-COVID research field was an over-emphasis on immune functioning and an under-emphasis on metabolism and energy production. While exercise studies showed up pretty early in chronic fatigue syndrome (ME/CFS), it took the field a while...
Every now and then my mouth gapes open with I read a paper. While the limitations of this paper must be noted – a small sample set involving three case reports – its conclusion – a very rapid return to health of people with severe long-term COVID...
We continue to take a deep dive into the “Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment” first-ever international conference on long COVID. Long-COVID research was always going to be a bit messy. Take a look at...
Another ME/CFS Moment Occurs Another ME/CFS “moment” – a sign that things are changing for people with ME/CFS and related diseases – recently occurred. It’s coming right on the heels of our last ME/CFS moment – last month’s...